2004
DOI: 10.1097/01.mjt.0000101827.94820.22
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Interaction of the HIV Protease Inhibitor Ritonavir with Herbal Constituents: Changes in P-gp and CYP3A4 Activity

Abstract: The purpose of this study was to evaluate in vitro interactions of commercially obtained pure herbal constituents with p-glycoprotein P-gp and cytochrome P-450 3A4 (CYP3A4) activities, which can further modulate the transcellular transport and metabolism kinetics of orally administered drugs. Caco-2 cells grown in the presence of 0.25 micromol/L 1alpha,25-dihydroxy vitamin D3 and multidrug-resistant 1 (MDR1) transfected MDCK cells were used as models to evaluate the effect of purified herbal constituents (quer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
94
0
2

Year Published

2006
2006
2012
2012

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 123 publications
(100 citation statements)
references
References 38 publications
4
94
0
2
Order By: Relevance
“…Recent work by Molnar et al [49] has shown that a wide range of naturally occurring lipophilic phytochemicals (diterpenes, triterpines and carotenoids) were able to inhibit human Pgp in vitro at the low lg/ml range, whereas other combinations had positive synergistic activity. Using purified polyphenols on Pgp overexpressing cells in vitro, Patel et al [59] showed that quercetin, hypericin and kaempferol were able to increase the cellular uptake of ritonavir by five-to eightfold. It is also interesting to note that in vitro assays or short-term exposure to these polyphenols in vivo appears to inhibit the action of efflux pumps and increase substrate bioavailability, whilst chronic exposure in healthy volunteers actually increases the expression of Pgp and, hence, reduces the bioavailability of efflux pump substrate drugs [14,27].…”
Section: Modulation Of Gut Mao Enzymesmentioning
confidence: 99%
“…Recent work by Molnar et al [49] has shown that a wide range of naturally occurring lipophilic phytochemicals (diterpenes, triterpines and carotenoids) were able to inhibit human Pgp in vitro at the low lg/ml range, whereas other combinations had positive synergistic activity. Using purified polyphenols on Pgp overexpressing cells in vitro, Patel et al [59] showed that quercetin, hypericin and kaempferol were able to increase the cellular uptake of ritonavir by five-to eightfold. It is also interesting to note that in vitro assays or short-term exposure to these polyphenols in vivo appears to inhibit the action of efflux pumps and increase substrate bioavailability, whilst chronic exposure in healthy volunteers actually increases the expression of Pgp and, hence, reduces the bioavailability of efflux pump substrate drugs [14,27].…”
Section: Modulation Of Gut Mao Enzymesmentioning
confidence: 99%
“…However, contradictory results have been published concerning the regulation of MDR-1/P-gp by HF. Patel et al 58 observed that HF caused a downregulation of MDR1 in human Caco-2 epithelial cells. In contrast, Tian et al 59 reported that SJW extracts and HF increased in a reversible way the expression and function of P-gp in the intestinal LS 180 cell line.…”
Section: Abc Transportersmentioning
confidence: 99%
“…A study with Caco-2 cells provided some in vitro evidence that OATP2B1 may be involved in the translocation of quercetin from the apical to the basal compartment [29]. Quercetin seems to be a potent inhibitor of the OATP1A2-and OATP2B1-mediated transport represented by the determined K i values in this study.Interestingly, quercetin is also a potent inhibitor of CYP3A4 and P-glycoprotein [30].Considering that quercetin is also one of the most abundant flavonoids, foods and herbal preparations containing quercetin may be therefore associated with a high risk for food-drug or drug-drug interactions by influencing the intestinal drug uptake, metabolism, and excretion. Furthermore, the potency of inhibition of OATP1A2 and OATP2B1 by apigenin and quercetin was different for the investigated substrates BSP, fexofenadine and atorvastatin.…”
mentioning
confidence: 99%